Cargando…

Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis

BACKGROUND: To perform a systematic review and network meta-analysis (NMA) to compare the risk of serious infections with immunosuppressive medications and glucocorticoids in lupus nephritis. METHODS: A trained librarian performed two searches: (1) PubMed for all lupus nephritis trials from the end...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Jasvinder A., Hossain, Alomgir, Kotb, Ahmed, Wells, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022202/ https://www.ncbi.nlm.nih.gov/pubmed/27623861 http://dx.doi.org/10.1186/s12916-016-0673-8

Ejemplares similares

Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysis
por: Singh, Jasvinder A., et al.
Publicado: (2016)

Individualized patient decision-aid for immunosuppressive drugs in women with lupus nephritis: study protocol of a randomized, controlled trial
por: Singh, Jasvinder A., et al.
Publicado: (2017)

The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug
por: Mejía-Vilet, Juan M., et al.
Publicado: (2021)

Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis
por: Jiang, Nan, et al.
Publicado: (2023)

Strongyloides Duodenitis in an Immunosuppressed Patient with Lupus Nephritis
por: Jegadeesan, Ramprasad, et al.
Publicado: (2018)

Analysis of the safety and efficacy of tacrolimus combined with glucocorticoid in the treatment of lupus nephritis
por: Li, Lu, et al.
Publicado: (2022)

Immunosuppressive Treatment for Lupus Nephritis: Long-Term Results in 178 Patients
por: Zakharova, Elena V., et al.
Publicado: (2016)

Minorities with lupus nephritis and medications: a study of facilitators to medication decision-making
por: Singh, Jasvinder A., et al.
Publicado: (2015)

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
por: Houssiau, Frédéric A, et al.
Publicado: (2010)

Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
por: Martínez, R, et al.
Publicado: (2010)

Relapse and Outcome of Lupus Nephritis After Renal Transplantation in the Modern Immunosuppressive Era
por: Pattanaik, Debendra, et al.
Publicado: (2022)

Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States
por: Hunnicutt, Jacob N., et al.
Publicado: (2023)

B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis—Role in Pathogenesis and Effect of Immunosuppressive Treatments
por: Yap, Desmond Y. H., et al.
Publicado: (2019)

Effectiveness and safety of common therapeutic drugs for refractory lupus nephritis: A network meta-analysis
por: Zhou, Jun, et al.
Publicado: (2020)

The Network of Inflammatory Mechanisms in Lupus Nephritis
por: Nozaki, Yuji
Publicado: (2020)

Sociodemographics and epidemiology of serious infections requiring hospitalization among adults with systemic lupus erythematosus and lupus nephritis, 2000 to 2006
por: Feldman, Candace H, et al.
Publicado: (2014)

Weaning of maintenance immunosuppressive therapy in lupus nephritis (WIN-Lupus): results of a multicentre randomised controlled trial
por: Jourde-Chiche, Noemie, et al.
Publicado: (2022)

Biomarkers Associated with Drugs for the Treatment of Lupus Nephritis
por: Nie, Huiyu, et al.
Publicado: (2023)

Neuropsychiatric Systemic Lupus Erythematosus with Cerebral Vasculitis and Lupus Nephritis Successfully Treated with High-dose Glucocorticoids and Mycophenolate Mofetil
por: Tanaka, Saki, et al.
Publicado: (2022)

Belimumab in Lupus Nephritis: A Systematic Review and Meta-Analysis
por: Shrestha, Sanjeev, et al.
Publicado: (2021)

Patient-Centered Outcomes Research Institute (PCORI) multisite project to develop treatment decision aids for racial/ethnic minorities with lupus nephritis
por: Yazdany, Jinoos, et al.
Publicado: (2014)

Long-Term Results of Triple Immunosuppression With Tacrolimus Added to Mycophenolate and Corticosteroids in the Treatment of Lupus Nephritis
por: Yap, Desmond Y.H., et al.
Publicado: (2021)

Multicentre retrospective cohort study assessing the incidence of serious infections in patients with lupus nephritis, compared with non-renal systemic lupus erythematosus
por: Yates, Drew Joseph, et al.
Publicado: (2020)

The Pathogenesis of Lupus Nephritis
por: Sterner, Rosalie M., et al.
Publicado: (2014)

Pediatric lupus nephritis
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2018)

Hyperhomocysteinemia and Lupus Nephritis
por: Timlin, Homa, et al.
Publicado: (2019)

Management of Lupus Nephritis
por: Tamirou, Farah, et al.
Publicado: (2021)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

Oral proprietary Chinese medicine for lupus nephritis: A bayesian network meta-analysis
por: Lin, Aitao, et al.
Publicado: (2023)

Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study
por: Lorenz, Hanns-Martin, et al.
Publicado: (2011)

Infective endocarditis in a patient with lupus nephritis who was undergoing immunosuppressive therapy: A case of survival
por: Ihara, Katsuhito, et al.
Publicado: (2017)

Infection-related hospitalization after intensive immunosuppressive therapy among lupus nephritis and ANCA glomerulonephritis patients
por: Yin, Peihong, et al.
Publicado: (2020)

Frequency of Dyslipidemia in patients with Lupus Nephritis
por: Sajjad, Saba, et al.
Publicado: (2017)

Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

Kidney disease in lupus is not always 'lupus nephritis'
por: Anders, Hans-Joachim, et al.
Publicado: (2013)

Micelle-Forming Dexamethasone Prodrug Attenuates Nephritis in Lupus-Prone Mice without Apparent Glucocorticoid Side Effects
por: Jia, Zhenshan, et al.
Publicado: (2018)

Dan Bai Xiao Formula combined with glucocorticoids and cyclophosphamide for pediatric lupus nephritis: A pilot prospective study
por: Cao, Tong-Tong, et al.
Publicado: (2022)

Lupus nephritis: current update
por: Saxena, Ramesh, et al.
Publicado: (2011)

The Role of Cytokine in the Lupus Nephritis
por: Iwata, Yasunori, et al.
Publicado: (2011)

Chapter 12: Lupus nephritis
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_01g99amau64t8ugunahp5s4ltg